PerkinElmer posts growth in Q2

By The Science Advisory Board staff writers

PerkinElmer posted revenue and operating income increases in its second quarter 2021 (end-July 4).

For the quarter, the company reported revenue in its Discovery and Analytical Solutions segment of $513 million, compared to $391 million for the same period in 2020. It posted operating income from continuing operations for the segment of $64 million, compared to $39 million for the second quarter of last year, and operating income of $101 million, compared to $57 million in the same period in 2020.

In other PerkinElmer news, the company announced that it will acquire antibody and research reagent manufacturer BioLegend for $5.25 billion.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?